These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 287191)

  • 1. The inhibitory effect of D-penicillamine on human lymphocyte cultures stimulated by phytohaemagglutinin, the antagonistic action of L-cysteine and synergistic inhibition by copper sulphate.
    Room G; Roffe L; Maini RN
    Scand J Rheumatol Suppl; 1979; (28):47-57. PubMed ID: 287191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression by D-penicillamine in vitro. Inhibition of human T lymphocyte proliferation by copper- or ceruloplasmin-dependent generation of hydrogen peroxide and protection by monocytes.
    Lipsky PE
    J Clin Invest; 1984 Jan; 73(1):53-65. PubMed ID: 6606652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suggested mode of action of D-penicillamine as an immunosuppressive agent in rheumatoid arthritis.
    Lipsky PE
    Z Rheumatol; 1988; 47 Suppl 1():6-8. PubMed ID: 2975107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro production and scavenging of hydrogen peroxide by D-penicillamine. Relationship to copper availability.
    Staite ND; Messner RP; Zoschke DC
    Arthritis Rheum; 1985 Aug; 28(8):914-21. PubMed ID: 4026887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the effects of the antirheumatic drugs, bucillamine and D-penicillamine, on mitogen-induced proliferation of mouse spleen cells.
    Mita S; Matsunaga K
    Agents Actions; 1990 Jun; 30(3-4):363-8. PubMed ID: 2386109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of D-penicillamine on mitogen-induced human lymphocyte proliferation: synergistic inhibition by D-penicillamine and copper salts.
    Lipsky PE; Ziff M
    J Immunol; 1978 Mar; 120(3):1006-13. PubMed ID: 632576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo inhibition of activation induced T cell apoptosis by bucillamine.
    Okazaki H; Sato H; Kamimura T; Hirata D; Iwamoto M; Yoshio T; Mimori A; Masuyama JI; Kano S; Minota S
    J Rheumatol; 2000 Jun; 27(6):1358-64. PubMed ID: 10852254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of mitogen-induced response of human peripheral blood mononuclear cells by bucillamine, a new antirheumatic sulfhydryl drug.
    Akamatsu T; Matsubara T; Saegusa Y; Mizuno K
    Rheumatol Int; 1994; 13(5):197-201. PubMed ID: 8202663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of DNA strand breaks by D-penicillamine and bucillamine in human lymphocytes.
    Yamanaka H; Hakoda M; Kamatani N; Kashiwazaki S; Carson DA
    Immunopharmacology; 1993; 26(2):113-8. PubMed ID: 8282535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of T cell-dependent antibody production by D-penicillamine. Different requirements for Cu2+ in suppression of polyclonal and antigen-specific B cell responses.
    Petersen J
    Allergy; 1987 Jan; 42(1):37-45. PubMed ID: 3551672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic inhibition of aminopeptidase B by penicillamine or cysteine and metallic salts.
    Herranz R; García-López MT; Pérez C
    Arch Pharm (Weinheim); 1991 Apr; 324(4):239-41. PubMed ID: 1863202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of B cell function by bucillamine, a novel disease-modifying antirheumatic drug.
    Hirohata S; Lipsky PE
    Clin Immunol Immunopathol; 1993 Jan; 66(1):43-51. PubMed ID: 8440072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-Penicillamine: analysis of the mechanism of copper-catalyzed hydrogen peroxide generation.
    Starkebaum G; Root RK
    J Immunol; 1985 May; 134(5):3371-8. PubMed ID: 2984288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine.
    Matsubara T; Saura R; Hirohata K; Ziff M
    J Clin Invest; 1989 Jan; 83(1):158-67. PubMed ID: 2463265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human helper T cell function in vitro by D-penicillamine and CuSO4.
    Lipsky PE; Ziff M
    J Clin Invest; 1980 May; 65(5):1069-76. PubMed ID: 6965944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro monocyte-lymphocyte interaction influenced by d-penicillamine.
    De Vries E; Haasnoot CJ; Van der Weij JP; Cats A
    Clin Exp Immunol; 1982 Feb; 47(2):474-80. PubMed ID: 7075029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro effects of two gold compounds, and D-penicillamine on the production of interferon gamma.
    Harth M; Cousin K; McCain GA
    Immunopharmacol Immunotoxicol; 1990; 12(1):39-60. PubMed ID: 2112569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D-penicillamine: mitogenic effect on mouse, rat and human spleen lymphocytes.
    Claësson MH; Hansen GS; Tjell V
    Med Microbiol Immunol; 1979 Aug; 167(3):161-74. PubMed ID: 315028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on the mechanism of action of D-penicillamine (DPA) on human lymphocytes (author's transl)].
    Feickert HJ; Schumacher K
    Arzneimittelforschung; 1980; 30(9):1480-3. PubMed ID: 7193012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of different doses of D-penicillamine and combined administration of D-penicillamine and methylprednisolone on collagen, glycosaminoglycans, DNA and RNA of granulation tissue, skin, bone and aorta in rats.
    Junker P; Helin G; Lorenzen I
    Acta Pharmacol Toxicol (Copenh); 1981 Nov; 49(5):366-80. PubMed ID: 6179388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.